RHAG and neoplasm: A plausible mechanism of their combined treatment is likely based on Rh2 targeting major players responsible for tumor adhesion, which is supported by DOX-induced nuclear damage to impair the cell ability to re-synthesize these proteins and enzymes executing cancer cell attachment and invasion.